Published in Strahlenther Onkol on March 28, 2009
The influence of different IMRT techniques on the peripheral dose: a comparison between sMLM-IMRT and helical tomotherapy. Strahlenther Onkol (2009) 0.94
Review of deep inspiration breath-hold techniques for the treatment of breast cancer. J Med Radiat Sci (2015) 0.93
Treatment techniques to reduce cardiac irradiation for breast cancer patients treated with breast-conserving surgery and radiation therapy: a review. Front Oncol (2014) 0.88
Quantitative assessment of irradiated lung volume and lung mass in breast cancer patients treated with tangential fields in combination with deep inspiration breath hold (DIBH). Strahlenther Onkol (2010) 0.85
The cardiac dose-sparing benefits of deep inspiration breath-hold in left breast irradiation: a systematic review. J Med Radiat Sci (2015) 0.84
Improving intra-fractional target position accuracy using a 3D surface surrogate for left breast irradiation using the respiratory-gated deep-inspiration breath-hold technique. PLoS One (2014) 0.80
Determination of the optimal matching position for setup images and minimal setup margins in adjuvant radiotherapy of breast and lymph nodes treated in voluntary deep inhalation breath-hold. Radiat Oncol (2015) 0.78
CT density in lung cancer patients after radiotherapy sensitized by metoclopramide. A subgroup analysis of a randomized trial. Strahlenther Onkol (2010) 0.77
Dose-Volume Analysis of Lung and Heart according to Respiration in Breast Cancer Patients Treated with Breast Conserving Surgery. J Breast Cancer (2012) 0.75
Dosimetric Considerations in Respiratory-Gated Deep Inspiration Breath-Hold for Left Breast Irradiation. Technol Cancer Res Treat (2016) 0.75
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet (2005) 24.57
Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med (1997) 10.83
Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet (1999) 8.44
Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. J Natl Cancer Inst (2005) 5.65
Cardiac exposures in breast cancer radiotherapy: 1950s-1990s. Int J Radiat Oncol Biol Phys (2007) 2.29
Locoregional failure 10 years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: experience of the Eastern Cooperative Oncology Group. J Clin Oncol (1999) 2.22
Should internal mammary lymph nodes in breast cancer be a target for the radiation oncologist? Int J Radiat Oncol Biol Phys (2000) 1.71
Internal mammary node irradiation neither decreases distant metastases nor improves survival in stage I and II breast cancer. Int J Radiat Oncol Biol Phys (2000) 1.52
Adjuvant radiotherapy for breast cancer significantly improves overall survival: the missing link. Radiother Oncol (2000) 1.26
Cardiac and lung complication probabilities after breast cancer irradiation. Radiother Oncol (2000) 1.09
DEGRO practical guidelines for radiotherapy of breast cancer I: breast-conserving therapy. Strahlenther Onkol (2007) 1.05
Regional nodal failure after conservative surgery and radiotherapy for early-stage breast carcinoma. J Clin Oncol (1991) 1.02
Second tumors after oncologic treatment. Strahlenther Onkol (2008) 0.98
Tumor location of the lower-inner quadrant is associated with an impaired survival for women with early-stage breast cancer. Ann Surg Oncol (2006) 0.95
Internal mammary nodal chain drainage is a prognostic indicator in axillary node-positive breast cancer. Ann Surg Oncol (2007) 0.90
Quality assurance in the EORTC randomized trial 22922/10925 investigating the role of irradiation of the internal mammary and medial supraclavicular lymph node chain works. Strahlenther Onkol (2006) 0.81
Radiotherapy of internal mammary lymph nodes in breast cancer. Principle considerations on the basis of dosimetric data. Strahlenther Onkol (2002) 0.80
Internal mammary nodes in invasive breast carcinoma. To treat or not to treat? Strahlenther Onkol (2004) 0.80
Internal mammary lymph node (IMN) coverage by standard radiation tangent fields in patients showing IMN drainage on lymphoscintigraphy: therapeutic implications. Am J Clin Oncol (2004) 0.79
[Whole-breast irradiation following breast-conserving surgery of ductal carcinomain situ is indispensable. Update of the 2005 DEGRO (German Society of Radiation Oncology) Guideline on Radiation Therapy for Breast Cancer]. Strahlenther Onkol (2006) 0.76
[Determination of organ doses and effective doses in radiooncology]. Strahlenther Onkol (2007) 0.75
Cardiac risks in multimodal breast cancer treatment. Strahlenther Onkol (2007) 0.75
Regional nodal recurrence in the management of breast cancer patients with one to three positive axillary lymph nodes. Outcome of patients following tangential irradiation without a separate nodal field. Strahlenther Onkol (2004) 0.75
Genetic polymorphisms in the vascular endothelial growth factor gene and breast cancer risk. The Austrian "tumor of breast tissue: incidence, genetics, and environmental risk factors" study. Breast Cancer Res Treat (2007) 1.28
Quality of life and sexual functioning after cervical cancer treatment: a long-term follow-up study. Psychooncology (2009) 1.26
Postoperative irradiation of left-sided breast cancer patients and cardiac toxicity. Does deep inspiration breath-hold (DIBH) technique protect the heart? Strahlenther Onkol (2008) 1.22
Common single nucleotide polymorphisms in the vascular endothelial growth factor gene and colorectal cancer risk. J Cancer Res Clin Oncol (2007) 1.01
Association of interleukin-10 gene variation with breast cancer prognosis. Breast Cancer Res Treat (2009) 1.00
Interleukin-10 [ATA] promoter haplotype and prostate cancer risk: a population-based study. Eur J Cancer (2006) 0.91
Analysis of common germline polymorphisms as prognostic factors in patients with lymph node-positive breast cancer. J Cancer Res Clin Oncol (2010) 0.90
Single nucleotide polymorphisms and haplotypes in the gene for vascular endothelial growth factor and risk of prostate cancer. Eur J Cancer (2008) 0.88
Methylenetetrahydrofolate reductase (MTHFR) and breast cancer risk: a nested-case-control study and a pooled meta-analysis. Breast Cancer Res Treat (2007) 0.88
Association between single nucleotide polymorphisms in the gene for XRCC1 and radiation-induced late toxicity in prostate cancer patients. Radiother Oncol (2011) 0.87
Long-term follow-up of patients with pituitary macroadenomas after postoperative radiation therapy: analysis of tumor control and functional outcome. Strahlenther Onkol (2007) 0.86
Preoperative oxaliplatin, capecitabine, and external beam radiotherapy in patients with newly diagnosed, primary operable, cT₃NxM0, low rectal cancer: a phase II study. Strahlenther Onkol (2011) 0.85
Association of hypoxia-inducible factor 1-alpha gene polymorphisms and colorectal cancer prognosis. Anticancer Res (2010) 0.84
Induction chemotherapy with docetaxel, cisplatin and 5-fluorouracil followed by radiotherapy with cetuximab for locally advanced squamous cell carcinoma of the head and neck. Eur J Cancer (2012) 0.83
Karnofsky performance status and lactate dehydrogenase predict the benefit of palliative whole-brain irradiation in patients with advanced intra- and extracranial metastases from malignant melanoma. Int J Radiat Oncol Biol Phys (2012) 0.82
A common and functional gene variant in the vascular endothelial growth factor a predicts clinical outcome in early-stage breast cancer. Mol Carcinog (2013) 0.81
The role of radiation therapy after incomplete resection of penile cancer. Strahlenther Onkol (2008) 0.81
Treatment results of radiation therapy for muscle-invasive bladder cancer. Strahlenther Onkol (2010) 0.81
Local tumour control and eye preservation after gamma-knife radiosurgery of choroidal melanomas. Br J Ophthalmol (2013) 0.80
The Glu228Ala polymorphism in the ligand binding domain of death receptor 4 is associated with increased risk for prostate cancer metastases. Prostate (2008) 0.79
A common gene variant in PLS3 predicts colon cancer recurrence in women. Tumour Biol (2013) 0.79
Performance analysis of a film dosimetric quality assurance procedure for IMRT with regard to the employment of quantitative evaluation methods. Phys Med Biol (2005) 0.79
Impact of VEGF gene polymorphisms and haplotypes on radiation-induced late toxicity in prostate cancer patients. Strahlenther Onkol (2011) 0.79
Association of vascular endothelial growth factor--a gene polymorphisms and haplotypes with breast cancer metastases. Acta Oncol (2014) 0.78
Association of common gene variants in vitamin D modulating genes and colon cancer recurrence. J Cancer Res Clin Oncol (2013) 0.78
Impact of dose rate on clinical course in uveal melanoma after brachytherapy with ruthenium-106. Strahlenther Onkol (2007) 0.77
IORT and external beam irradiation (EBI) in clinical stage I-II NSCLC patients with severely compromised pulmonary function: an 52-patient single-institutional experience. Strahlenther Onkol (2007) 0.76
TGFB1 single-nucleotide polymorphisms are associated with adverse quality of life in prostate cancer patients treated with radiotherapy. In regard to Peters et al. (Int J Radiat Oncol Biol Phys 2008;70:752-759). Int J Radiat Oncol Biol Phys (2008) 0.76
Genetic prediction of radiation-induced morbidity in prostate cancer patients. Radiother Oncol (2012) 0.75
A common hereditary single-nucleotide polymorphism in the gene of FAS and colorectal cancer survival. J Cell Mol Med (2009) 0.75
Single nucleotide polymorphisms of integrin alpha-2 and beta-3 genes are not associated with relapse-free and overall survival in colorectal cancer patients. Anticancer Res (2011) 0.75
Calling attention to radiation recall reactions. Simultaneous occurrence of a Recall Dermatitis after CMF application in two separate sites irradiated 10 years apart. Acta Oncol (2011) 0.75
The functional polymorphism of erythropoietin gene rs1617640 G>T is not associated with susceptibility and clinical outcome of early-stage breast cancer. Anticancer Res (2012) 0.75
Prostate cancer radiotherapy in Austria: overview on number of patients, intention to treat, and treatment techniques based on data from 2007. Strahlenther Onkol (2011) 0.75